Burak Bi̇lgi̇n

1.1k total citations
57 papers, 613 citations indexed

About

Burak Bi̇lgi̇n is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Management Science and Operations Research. According to data from OpenAlex, Burak Bi̇lgi̇n has authored 57 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 13 papers in Management Science and Operations Research. Recurrent topics in Burak Bi̇lgi̇n's work include Scheduling and Timetabling Solutions (13 papers), Vehicle Routing Optimization Methods (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Burak Bi̇lgi̇n is often cited by papers focused on Scheduling and Timetabling Solutions (13 papers), Vehicle Routing Optimization Methods (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Burak Bi̇lgi̇n collaborates with scholars based in Türkiye, Belgium and Kuwait. Burak Bi̇lgi̇n's co-authors include Emin Erkan Korkmaz, Ender Özcan, Patrick De Causmaecker, Mehmet Alı Nahıt Şendur, Bülent Yalçın, Greet Vanden Berghe, Peter Demeester, Muhammed Bülent Akıncı, Didem Şener Dede and Greet Van den Berghe and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Burak Bi̇lgi̇n

45 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Burak Bi̇lgi̇n Türkiye 12 250 211 138 123 97 57 613
Jiheng Zhang China 16 43 0.2× 107 0.5× 22 0.2× 28 0.2× 56 0.6× 71 779
Gareth Beddoe United Kingdom 10 133 0.5× 113 0.5× 73 0.5× 159 1.3× 237 2.4× 22 575
Mücahit Çevik Canada 14 41 0.2× 65 0.3× 272 2.0× 232 1.9× 172 1.8× 58 815
Ingrid Vliegen Netherlands 11 68 0.3× 58 0.3× 66 0.5× 27 0.2× 17 0.2× 23 423
Adam Janiak Poland 28 121 0.5× 2.2k 10.6× 106 0.8× 132 1.1× 51 0.5× 104 2.6k
G. Srinivasan India 18 27 0.1× 316 1.5× 23 0.2× 23 0.2× 60 0.6× 79 925
Jinn‐Yi Yeh Taiwan 12 41 0.2× 175 0.8× 27 0.2× 179 1.5× 20 0.2× 29 551
Rahul Nath India 16 63 0.3× 116 0.5× 27 0.2× 193 1.6× 12 0.1× 33 728
Ernesto Nunes United States 9 48 0.2× 151 0.7× 56 0.4× 88 0.7× 13 0.1× 15 480
Robert M. Goldberg United States 11 47 0.2× 31 0.1× 145 1.1× 177 1.4× 53 0.5× 16 741

Countries citing papers authored by Burak Bi̇lgi̇n

Since Specialization
Citations

This map shows the geographic impact of Burak Bi̇lgi̇n's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burak Bi̇lgi̇n with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burak Bi̇lgi̇n more than expected).

Fields of papers citing papers by Burak Bi̇lgi̇n

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burak Bi̇lgi̇n. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burak Bi̇lgi̇n. The network helps show where Burak Bi̇lgi̇n may publish in the future.

Co-authorship network of co-authors of Burak Bi̇lgi̇n

This figure shows the co-authorship network connecting the top 25 collaborators of Burak Bi̇lgi̇n. A scholar is included among the top collaborators of Burak Bi̇lgi̇n based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burak Bi̇lgi̇n. Burak Bi̇lgi̇n is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bi̇lgi̇n, Burak, Bülent Yalçın, Muhammed Bülent Akıncı, et al.. (2025). Palliative Radiotherapy in Metastatic Breast Cancer Patients on CDK4/6 Inhibitors: Safety Analysis. Cancers. 17(3). 424–424. 1 indexed citations
2.
Bi̇lgi̇n, Burak, Şebnem Çınar Yücel, Mehmet Alı Nahıt Şendur, et al.. (2025). The effect of dose reduction of CDK4/6 inhibitors on survival in postmenopausal HR+ HER2-negative metastatic breast cancer. Expert Review of Anticancer Therapy. 25(5). 579–588.
3.
4.
Bi̇lgi̇n, Burak, et al.. (2024). Prognostic importance of prognostic nutritional index and modified Glasgow prognostic score in advanced lung cancer with targetable mutation. Journal of Cancer Research and Clinical Oncology. 150(4). 215–215. 1 indexed citations
5.
Dede, Didem Şener, Burak Bi̇lgi̇n, Şebnem Çınar Yücel, et al.. (2024). Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer. Journal of Clinical Medicine. 14(1). 173–173.
6.
Avcı, Nilüfer, Ali Alkan, Yakup Ergün, et al.. (2024). Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment. Scientific Reports. 14(1). 10632–10632.
7.
8.
Bi̇lgi̇n, Burak, Mehmet Alı Nahıt Şendur, Nalân Akyürek, et al.. (2021). The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement. Journal of Cancer Research and Clinical Oncology. 147(9). 2637–2643.
9.
Bi̇lgi̇n, Burak, et al.. (2020). The association of clinicopathologic features and peripheral blood parameters with high PD-L1 expression in non-small cell lung cancer. Tuberkuloz ve Toraks. 68(2). 118–125. 3 indexed citations
10.
Bi̇lgi̇n, Burak, et al.. (2019). Üniversitede Öğrenim Gören Hentbolcuların Serbest Zaman Tatmin ve Yaşam Doyum Düzeylerinin İncelenmesi. DergiPark (Istanbul University). 4(2). 50–60. 1 indexed citations
11.
Dızdar, Ömer, Nuriye Özdemir, Nurullah Zengin, et al.. (2019). The frequency and predictors of persistent amenorrhea in premenopausal women with colorectal cancer who received adjuvant chemotherapy. Anti-Cancer Drugs. 30(3). 289–294. 2 indexed citations
12.
Şendur, Mehmet Alı Nahıt, et al.. (2018). Prognostic effect of red cell distribution width-to-platelet ratio in colorectal cancer according to tumor stage and localization. Journal of Cancer Research and Therapeutics. 15(1). 54–54. 16 indexed citations
13.
Doğan, Hayriye Tatlı, Burak Bi̇lgi̇n, Mehmet Alı Nahıt Şendur, et al.. (2018). Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression. Diagnostic Pathology. 13(1). 60–60. 22 indexed citations
14.
Şendur, Mehmet Alı Nahıt, et al.. (2018). Mutational status of lung cancer patients and survival outcomes for patients with limited brain metastases.. PubMed. 23(7). 156–156. 2 indexed citations
15.
Dede, Didem Şener, Hayriye Tatlı Doğan, Berrak Gümüşkaya, et al.. (2017). The association of programmed death-ligand 1 (PD-L1), programmed cell death (PD-1), tumor infiltrating lymphocytes(TILs) and isocitrate dehydrogenase (IDH-1) mutation in glioblastome multiforme(GBM). Annals of Oncology. 28. v110–v110. 1 indexed citations
16.
Dede, Didem Şener, Hayriye Tatlı Doğan, Berrak Gümüşkaya, et al.. (2017). The association and prognostic significance of programmed death-ligand 1 (PD-L1) and isocitrate dehydrogenase (IDH-1) mutation in glioblastome multiforme(GBM) patients.. Journal of Clinical Oncology. 35(15_suppl). e13536–e13536. 1 indexed citations
17.
Keleş, Osman Nuri, Ahmet Selçuk Can, Suat Çolak, et al.. (2014). Hepatoprotective Effects of B-1,3-(D)-Glucan on Bortezomib- Induced Liver Damage in Rats. Kafkas Universitesi Veteriner Fakultesi Dergisi. 20(6). 929–938. 8 indexed citations
18.
Yıldırım, Cem, et al.. (2014). Investigation of the effects of alpha lipoic acid application on total antioxidant and oxidant status, paraoxonase, and total sialic acid levels in laminectomized rabbits.. Kafkas Universitesi Veteriner Fakultesi Dergisi. 20(1). 111–116. 1 indexed citations
19.
Bi̇lgi̇n, Burak, et al.. (2010). Local search neighbourhoods for dealing with a novel nurse rostering model. Annals of Operations Research. 194(1). 33–57. 45 indexed citations
20.
Bi̇lgi̇n, Burak, et al.. (2009). Towards prediction of algorithm performance in real world optimisation problems. Lirias (KU Leuven). 177–183. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiheng Zhang Breakdown of academic impact, for papers by Gareth Beddoe Breakdown of academic impact, for papers by Mücahit Çevik Breakdown of academic impact, for papers by Ingrid Vliegen Breakdown of academic impact, for papers by Adam Janiak Breakdown of academic impact, for papers by G. Srinivasan Breakdown of academic impact, for papers by Jinn‐Yi Yeh Breakdown of academic impact, for papers by Rahul Nath Breakdown of academic impact, for papers by Ernesto Nunes Breakdown of academic impact, for papers by Robert M. Goldberg
Rankless by CCL
2026